CIPO Submission to CADTH

Thank you to all our members who participated in our recent survey on treatment. CIPO used the data collected to create a patient submission to the CADTH (Canadian Agency on Drugs and Technology in Heath) for a new product that is currently being reviewed. You can...

COVID Antibody Study in Immune Deficiency Patients

CIPO is proud to partner with the Ottawa Hospital and lead investigator Dr. Juthaporn Cowan as they launch the VISID (Vaccine Immunogenicity and Safety in ImmunoDeficiency patients) study. This study which will look at effectiveness, safety and immune response in...